Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CPRX | Options to purchase common stock | Options Exercise | $0 | -230K | -8.87% | $0.00 | 2.36M | Nov 11, 2024 | Common Stock | 230K | $4.01 | Direct | F5 |
transaction | CPRX | Options to purchase common stock | Options Exercise | $0 | -70K | -2.96% | $0.00 | 2.29M | Nov 12, 2024 | Common Stock | 70K | $4.01 | Direct | F5 |
transaction | CPRX | Options to purchase common stock | Options Exercise | $0 | -192K | -8.37% | $0.00 | 2.1M | Nov 12, 2024 | Common Stock | 192K | $3.54 | Direct | F6 |
Id | Content |
---|---|
F1 | Shares were sold for personal reasons, including paying federal income taxes and diversifying the Reporting Person's portfolio. Shares were not sold as a result of any disagreement with the Company. Mr. McEnany remains the non-executive chairman of the Company's Board of Directors and the Company's largest individual, non-institutional shareholder. |
F2 | Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.29 to $23.873 per share. |
F3 | Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.30 to $23.50 per share. |
F4 | Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.03 to $23.48 per share. |
F5 | Options vested in three equal tranches on January 2, 2019, 2020 and 2021. |
F6 | Options vested in three equal tranches on May 29, 2019, 2020 and 2021. |